Trump's False Claim on Prescription Drug Prices
President Donald Trump has made a grandiose claim about reducing prescription drug prices by up to 1,500%, but experts say this is mathematically impossible. The administration has taken steps to lower prices, but there is no indication that costs have seen such a massive drop.
Key Takeaways:
- The Trump administration's claim of cutting drug prices by 1,500% is false, as it would mean drug companies would be paying customers to take medications.
- Experts agree that there has been no indication of a substantial cut in drug prices, with some going as far as to call Trump's claim "total fiction".
- The White House provided a chart of price differentials for drugs in the U.S. and comparable countries, but offered no other evidence to support the claim.
- Pharmaceutical manufacturers have indicated that they will not cut costs to the extent Trump claims, and have not made public announcements about price cuts.
- The federal government has the most power to shape the price it pays for drugs covered by Medicare and Medicaid, but it is unclear what impact the Trump administration's efforts will have on millions of Americans with private health insurance.
Statistics:
- According to the White House, prices for most prescription drugs are higher in the U.S. than in other high-income countries.
- Trump's executive order sets a 30-day deadline for drugmakers to electively lower prices in the U.S. or face new limits.
- Pharmaceutical manufacturers have the most to gain from price cuts, with some companies seeing profits of up to 50% on certain medications.
- The most expensive medications are often those used to treat chronic conditions, such as arthritis and diabetes.
- Medicare and Medicaid cover around 40% of prescription drug costs in the U.S.
Sources:
- "Trump says drug prices will drop by '1,200, 1,300, 1,300, 1,400, 1,400%' - AP," The Associated Press, 2025.
- "AP Fact Check: Trump's claim on cutting drug prices - AP," The Associated Press, 2025.
- "Prescription drug prices - FDA," Food and Drug Administration, 2025.